SEC 13F Intelligence

Taconic Capital Advisors LP / ALXN

Taconic Capital Advisors LP’s Alexion Pharmaceuticals Inc Position

Does Taconic Capital Advisors LP own Alexion Pharmaceuticals Inc (ALXN)? Not currently — the last reported position was 1.48M shares worth $272M in Q2 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$272M
Q2 2021
Shares
1.48M
% of Portfolio
+8.44%
Quarters Held
3
position exited

Position History ALXN

Reported value by quarter
Q4 ’19: $3MQ4 ’19Q1 ’21: $150MQ1 ’21Q2 ’21: $272MQ2 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20211.48M$272M+8.44%
Q1 2021980.0K$150M+5.31%
Q4 201930.0K$3M+0.11%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Taconic Capital Advisors LP’s full portfolio or all institutional holders of ALXN.